Healthcare -
Biotechnology - NASDAQ - US
$ 6.7
-8.34 %
$ 70.1 M
Market Cap
0.07
P/E
AVTX - GROSS PROFIT
Gross Profit AVTX - Avalo Therapeutics, Inc.
640 K
LAST VALUE
-59.53%
2 YEAR CAGR
-43.22%
5 YEAR CAGR
0.00%
10 YEAR CAGR